LEVER 发表于 2025-3-25 04:31:35

Submitted on: 21 January 2021.
Revised on: 10 February 2021.
Accepted on: 26 February 2021.
NICOTINE & TOBACCO RESEARCH---OXFORD UNIV PRESS

obligation 发表于 2025-3-25 08:59:38

http://reply.papertrans.cn/3/232/23152/23152-22.png

无法破译 发表于 2025-3-25 12:27:33

Submitted on: 15 January 2017.
Revised on: 12 February 2017.
Accepted on: 18 February 2017.
NICOTINE & TOBACCO RESEARCH

询问 发表于 2025-3-25 19:12:35

Submitted on: 27 July 2012.
Revised on: 28 August 2012.
Accepted on: 16 September 2012.
NICOTINE & TOBACCO RESEARCH---OXFORD UNIV PRESS

Generic-Drug 发表于 2025-3-25 22:36:46

http://reply.papertrans.cn/3/232/23152/23152-25.png

星星 发表于 2025-3-26 03:45:02

http://reply.papertrans.cn/3/232/23152/23152-26.png

opinionated 发表于 2025-3-26 08:07:15

http://reply.papertrans.cn/3/232/23152/23152-27.png

erythema 发表于 2025-3-26 09:23:37

Submitted on: 12 July 2011.
Revised on: 30 July 2011.
Accepted on: 24 August 2011.
NICOTINE & TOBACCO RESEARCH

提升 发表于 2025-3-26 14:15:30

http://reply.papertrans.cn/3/232/23152/23152-29.png

纯朴 发表于 2025-3-26 18:08:05

Submitted on: 16 September 2009.
Revised on: 08 October 2009.
Accepted on: 28 October 2009.
NICOTINE & TOBACCO RESEARCH---OXFORD UNIV PRESS
页: 1 2 [3] 4
查看完整版本: SCIE期刊NICOTINE & TOBACCO RESEARCH 2024/2025影响因子:3.105 (NICOTINE TOB RES) (1462-2203). (SUBSTANCE ABUSE)(药物滥用)Science Ci